» Articles » PMID: 12649175

A Nodal- and ALK4-independent Signaling Pathway Activated by Cripto-1 Through Glypican-1 and C-Src

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Mar 22
PMID 12649175
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Human Cripto-1 (CR-1) is a member of the epidermal growth factor-Cripto FRL1 Cryptic family that has been shown to function as a coreceptor with the type I Activin serine-threonine kinase receptor ALK4 for the transforming growth factor beta-related peptide Nodal. However, CR-1 can also activate the mitogen-activated protein kinase and Akt pathways independently of Nodal and ALK4 by an unknown mechanism. Here, we demonstrate that CR-1 specifically binds to Glypican-1, a membrane-associated heparan sulfate proteoglycan, and activates the tyrosine kinase c-Src, triggering the mitogen-activated protein kinase and Akt signaling pathways. Finally, an active Src kinase is necessary for CR-1 to induce in vitro transformation and migration in mouse mammary epithelial cells.

Citing Articles

Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action.

Li M, Wang Y, Lin X, Yang H, Zhang X, Bai Y Explor Target Antitumor Ther. 2024; 5(3):600-626.

PMID: 38966167 PMC: 11220310. DOI: 10.37349/etat.2024.00238.


Whence CRIPTO: The Reemergence of an Oncofetal Factor in 'Wounds' That Fail to Heal.

Freeman D, Rodrigues Sousa E, Karkampouna S, Zoni E, Gray P, Salomon D Int J Mol Sci. 2021; 22(18).

PMID: 34576327 PMC: 8472190. DOI: 10.3390/ijms221810164.


Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells.

Arnouk H, Yum G, Shah D Int J Mol Sci. 2021; 22(17).

PMID: 34502188 PMC: 8430685. DOI: 10.3390/ijms22179280.


Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma.

Hu C, Zhang Y, Zhang M, Li T, Zheng X, Guo Q Front Oncol. 2021; 11:730615.

PMID: 34434900 PMC: 8380828. DOI: 10.3389/fonc.2021.730615.


New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates.

Arboretto P, Cillo M, Leonardi A Int J Mol Sci. 2021; 22(15).

PMID: 34360603 PMC: 8345935. DOI: 10.3390/ijms22157838.